Lee Jackson
6 min read
Quick Read
-
A $25,000 split evenly across Johnson & Johnson, Procter & Gamble, Exxon Mobil and Realty Income throws off roughly $799 in yearly dividends.
-
Each pick has raised its payout for decades and covers it comfortably, with payout ratios between about 46% and 73%.
-
Realty Income’s monthly 5.67% yield supplies about $355 of the total, while reinvesting payouts compounds income for investors still years from retirement.
-
Read More: Learn 7 ways to generate income with a $1,000,000+ portfolio (sponsor)
Retirement changes what a portfolio is for. Once the paycheck stops, the number that matters most is how much cash the account sends back each year without pushing a sale of shares. For near-retirees and new retirees building a first income layer, companies with well-covered dividends that keep rising are a durable place to start.
A $6,250 stake in each of these four dividend payers, $25,000 in total, would generate about $799 in annual income, which tops the $750 mark. The group covers healthcare, consumer staples, energy and real estate, and every company on it has raised its payout for decades. The yields below are forward figures based on each company’s latest declared dividend and current share price.
Johnson & Johnson Brings 64 Years of Raises
-
Stock #4: Johnson & Johnson (NYSE:JNJ)
-
Yield: 1.95%
-
Shares for $6,250: 22.69
-
Annual Passive Income: ~$121.62
Johnson & Johnson runs two businesses. Innovative Medicine posted Q2 2026 revenue of $16.38 billion (+7.8%), and MedTech brought in $8.93 billion (+4.5%). J&J is a mature operating company that spends heavily on its drug pipeline, so its yield is modest. A 36.84% year-to-date share gain has pushed it lower still.
The dividend is well covered. Management raised 2026 adjusted EPS guidance to $11.60 to $11.75, while the annual dividend is $5.36. That works out to a payout ratio of roughly 46%. Free cash flow reached $19.7 billion in 2025, and the increase to $1.34 per quarter was J&J’s 64th straight year of dividend growth. The company also agreed to buy Ollin Biosciences. The main risk is biosimilar competition: STELARA sales fell 55.2% in Q2.
——
Learn 7 Ways To Generate Income With A $1,000,000+ Portfolio
If you’ve saved over $1,000,000, this guide is for you. The last thing you want in retirement is to run out of money, you want your money to generate lasting income while you enjoy your life.
Now you can learn the strategies wealthy retirees use to fund their retirement with The Definitive Guide to Retirement Income from Fisher Investments. Download the guide today! (sponsor)